Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asana Inc. (ASAN) vs Koninklijke Philips NV (PHG) Price & Performance

Asana Inc.
Koninklijke Philips NV

Price performance

Price movement over the last 24 hours

Key statistics

Asana Inc. vs Koninklijke Philips NV — how do they compare? Asana Inc. trades at $7.36 (market cap $1.69B), while Koninklijke Philips NV trades at $27.4 (market cap $26.63B). The key difference: Koninklijke Philips NV is far larger — about 15.8× Asana Inc.'s market cap, and Koninklijke Philips NV pays a 3.7% dividend while Asana Inc. pays none. Which is the better fit depends on your goals.

ASANPHG
Market Cap
$1.69B$26.63B
Sector
Consumer CyclicalHealth
52-Week High
$15.35$32.91
52-Week Low
$5.46$24.03
Enterprise Value
$1.51B$32.90B
Dividend Yield
3.7%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Asana Inc.

Asana (ASAN) trades at $7.33, down 0.54% with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue growth from $378M in 2022 to $724M in 2025, though net losses persist. Recent Q1 2027 earnings beat expectations at $0.10 per share, and strategic acquisitions like StackAI enhance AI capabilities. Analyst consensus is mixed with 42% buy ratings and a $9.86 price target, representing 35% upside from current levels.

The outlook balances growth potential against profitability challenges. Positive catalysts include FedRAMP authorization for government contracts and AI innovation, but risks stem from intense competition with Microsoft and decelerating revenue growth. Cash flow turned positive in 2025, yet negative margins and high valuation multiples require careful monitoring for sustained improvement.

Koninklijke Philips NV

Royal Philips (PHG) trades at $27.40, up 0.51% today, with a bullish technical signal despite mixed moving averages. The company shows improving fundamentals with net income turning positive to $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent FDA clearances for AI-powered medical devices and strategic healthcare partnerships highlight growth initiatives. Analyst consensus leans neutral with 40.9% buy ratings amid stable revenue around $17.8 billion.

PHG presents a recovery story with margin expansion and AI innovation driving upside potential, though execution risks and debt levels near 25% of assets warrant caution. The stock's 24.1 P/E appears reasonable if earnings growth sustains, but investors should monitor competitive pressures in healthcare technology and macroeconomic impacts on capital spending.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Asana Inc.

Asana Inc is a software company. The company provides a platform for work management that helps teams orchestrate work, from daily tasks to cross-functional strategic initiatives. It helps plan marketing campaigns, streamlines processes, manages sales, and manage product launches. Also, the company provides project management and workflow management solutions.

Read more on ASAN

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG